user

The rate of M-protein decrement predicts survival in multiple myeloma.

被引：0
|
作者：
Schaar, CG
le Cessie, S
te Marvelde, CM
Wijermans, PW
Kluin-Nelemans, HC
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Ctr Comprehens Canc W, Datamanagement, Leiden, Netherlands
[3] Leyenburg Hosp, The Hague, Netherlands
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
670
引用
收藏
页码：156A / 156A
页数：1
相关论文
共 50 条
  • [1] REASSESSMENT OF THE RELATIONSHIP BETWEEN M-PROTEIN DECREMENT AND SURVIVAL IN MULTIPLE-MYELOMA
    PALMER, M
    BELCH, A
    HANSON, J
    BROX, L
    [J]. BRITISH JOURNAL OF CANCER, 1989, 59 (01) : 110 - 112
  • [2] Importance of posttreatment nadir M-protein level in the evaluation of the treatment for multiple myeloma.
    Shimizu, K
    Kamiya, O
    Takeyama, H
    Mizuno, H
    Kawashima, K
    [J]. BLOOD, 1997, 90 (10) : 4112 - 4112
  • [3] Early M-Protein Dynamics Predicts Progression-Free Survival in Patients With Relapsed/Refractory Multiple Myeloma
    Yan, Xiaoyu
    Xu, Xu Steven
    Weisel, Katja C.
    Mateos, Maria-Victoria
    Sonneveld, Pieter
    Dimopoulos, Meletios A.
    Usmani, Saad Zafar
    Bahlis, Nizar J.
    Puchalski, Thomas
    Ukropec, Jon
    Bellew, Kevin
    Ming, Qi
    Sun, Steven
    Zhou, Honghui
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (06): : 1345 - 1354
  • [4] Establishing the Velocity of M-Protein Decline (VMD) Value in Response to Multiple Myeloma Therapy That Best Predicts M-Protein of Zero
    Haddad, Philip A.
    Ganey, Nowell
    [J]. BLOOD, 2020, 136
  • [5] MULTIPLE-MYELOMA WITHOUT M-PROTEIN
    AMIR, J
    [J]. JOURNAL OF THE ARKANSAS MEDICAL SOCIETY, 1978, 75 (03): : 118 - 118
  • [6] Changes in M-Protein at Multiple Myeloma Relapse
    Hobbs, J. A.
    Sharp, K.
    Harding, S. J.
    Drayson, M.
    Bradwell, A. R.
    Mead, G. P.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S27 - S27
  • [7] Posttreatment M-protein nadir level is a significant prognostic factor associated with survival in multiple myeloma
    Shimizu, K
    Kamiya, O
    Hirabayashi, N
    Ichikawa, A
    Kawashima, K
    Kobayashi, M
    Mizuno, H
    Nagura, E
    Nitta, M
    Saito, H
    Sao, H
    Shibata, T
    Takeyama, H
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (03): : 355 - 360
  • [8] Atypical M-protein localization in protein electrophoresis in a patient with multiple myeloma
    Yildirim, Naciye Demirel
    Ayer, Mesut
    Hatipoglu, Esra
    Kucukkaya, Reyhan Diz
    Yenerel, Mustafa Nuri
    Nalcaci, Meliha
    [J]. TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2008, 25 (01): : 56 - 59
  • [9] Reduction In Proliferative Rate of Myeloma Plasma Cells Measured by the Plasma Cell Labeling Index Predicts Improved Survival In Multiple Myeloma.
    Larsen, Jeremy T.
    Chee, Cheng E.
    Lust, John
    Greipp, Philip R.
    Rajkumar, S. Vincent
    [J]. BLOOD, 2010, 116 (21) : 1650 - 1650
  • [10] MODELING M-PROTEIN DYNAMICS IN SUBJECTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING VENETOCLAX: UTILITY OF EARLY M-PROTEIN MONITORING TO PREDICT PROGRESSION FREE SURVIVAL
    Liu, S.
    Salem, A.
    Ross, J.
    Bueno, O.
    Badawi, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S67 - S67
12345